Hauttumore nach Organtransplantation

M. Hackethal; C. Ulrich; E. Stockfleth

doi:10.1055/s-2006-947806

DMW - Deutsche Medizinische Wochenschrift, Table of Contents

Dtsch Med Wochenschr 2006; 131(28/29): 1609-1613
DOI: 10.1055/s-2006-947806

Übersicht | Review article

Dermatologie, Transplantationsmedizin
© Georg Thieme Verlag KG Stuttgart · New York

Hauttumore nach Organtransplantation

Skin cancer after organ transplantationM. Hackethal¹ , C. Ulrich¹ , E. Stockfleth¹

¹Klinik für Dermatologie, Venerologie und Allergologie, Charité, Humboldt-Universität Berlin

Abstract

Schlüsselwörter

Immunsuppression - Organtransplantation - Malignome der Haut - Flächenkarzinose - nicht-melanozytäre Hauttumoren - aktinische Keratose

Key words

immunosuppression - transplantation - skin cancer - field cancerization - nonmelanoma skin cancer - actinic keratosis

Full Text

References

Literatur

1 Berg C, Otley C C. Skin cancer in organ tranplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002; 47 1-17
2 Brown V L, Atkins C L, Ghali L, Cerio R, Harwood C A, Proby C M. Safety and efficacy of 5 % imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients. Arch Dermatol. 2005; 141 985-993
3 Buell J F, Trofe J, Hanaway M J. et al . Immunosuppression and Merkel cell cancer. Transplant Proc. 2002; 34 1780-1781
4 Capello D, Rossi D, Gaidano G. Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis. Hematol Oncol. 2005; 23 61-67
5 Carucci J A, Martinez J C, Zeitouni N C. et al . In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients. Dermatol Surg. 2004; 30 651-655
6 Clayton A S, Stasko T. Treatment of nonmelanoma skin cancer in organ transplant recipients. J Am Acad Dermatol. 2003; 49 413-416
7 O’Donovan P, Perrett C M, Zhang X. et al . Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005; 309 1871-1874
8 Dragieva G, Hafner J, Dummer R. et al . Topical photodynamic therapy in the treatment of actinic keratoses and BowenŽs disease in transplant recipients. Transplantation. 2004; 77 115-121
9 Euvrard S, Ulrich C, Lefrancois N. Immunosuppressants and skin cancer in transplant patients.. Dermatol Surg. 2004; 30 628-633
10 Fortina A B, Piaserico S, Caforio A L. et al . Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol. 2004; 140 1079-1085
11 Fritsch C. et al . Photodynamic Diagnosis and Therapy in Dermatology. Skin Pharmacol Appl Skin Physiol. 1998; 11 358-373
12 Gerlini G, Romagnoli P, Pimpinelli N. Skin cancer and immunosuppression. Crit Rev Oncol Hematol. 2005; 56 127-136
13 de Graaf Y G. et al . Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients. J Invest Dermatol. 2006; 126 569-574
14 Jorizzo J L. Current and novel treatment options for actinic keratosis. J Cutan Med Surg. 2004; 8 13-21
15 Kanitakis J, Alhaj-Ibrahim L, Euvrard S, Claudy A. Basal cell carcinomas in solid organ transplant recipients. Arch Dermatol. 2003; 139 1133-1137
16 Karagas M R, Cushing G L, Greenberg E R. et al . Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer. 2001; 85 683-686
17 Kovach B T, Sams H H, Stasko T. Systemic strategies for chemoprevention of skin cancers in transplant recipients. Clin Transplant. 2005; DOI: 10.1111/j.13990012.2005.00412.x;
18 Kovach B T, Stasko T. Use of topical immunmodulators in organ transplant recipients. Dermatol Ther. 2005; 18 19-27
19 Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG) AWMF-Leitlinien-Register Nr. 013/041 .Aktinische Keratose. www.uni-duesseldorf.de/AWMF/ll/ll_derma.htm.
20 Lok C, Viseux V, Denoeux J P, Bagot M. Post-transplant T-cell-lymphomas. Crit Rev Oncol Hematol. 2005; 56 137-145
21 Otley C C, Berg D, Ulrich C. et al . Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol. 2006; 154 395-400
22 Parrish J A. Immunosuppression, skin cancer, and ultraviolet A radiation. N Engl J Med. 2005; 353 2712-2713
23 Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol. 2004; 5 593-599
24 Rao J. Let There Be Light: An overview of cutaneous photodynamic therapy. www.departmentofmedicine.ualberta.ca/mgr_09-10-04.htm
25 Rivers J K, Arlette J, Shear N, Guenther N, Carey W, Poulin Y. Topical treatment of actinic keratoses with 3 % diclofenac in 2,5 % hyaluron gel. Br J Dermatol. 2002; 146 94-100
26 Shuttleworth D, Marks R, Griffin P J, Salaman J R. Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprine. Br J Dermatol. 1989; 120 551-554
27 Smith K J, Germain M, Skelton H. Squamous cell carcinoma in situ (BowenŽs disease) in renal transplant patients treated with 5 % imiquimod and 5 % 5-Fluorouracil therapy. Dermatol Surg. 2001; 27 561-564
28 Stallone G, Schena A, Infante B. et al . Sirolimus for KaposiŽs sarcoma in renal-transplant recipients. N Engl J Med. 2005; 352 1317-1323
29 Stockfleth E, Christophers E, Benninghoff B, Sterry W. Low incidence of new actinic keratoses after topical 5 % imiquimod cream treatment: a long-term follow-up study. Arch Dermatol. 2004; 140 1542
30 Stockfleth E, Meyer T, Benninghoff B. et al . A randomized, double blind, vehicle-controlled study to assess 5 % imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol. 2002; 138 1498-1502
31 Testerman T L, Gerster J F, Imbertson L M. et al . Cytokine induction by the immunmodulators imiquimod and S-27 609. J Leukoc Biol. 1995; 58 365-372
32 Ulrich C, Christophers E, Sterry W, Meyer T, Stockfleth E. Hauterkrankungen bei organtransplantierten Patienten. Hautarzt. 2002; 53 524-533
33 Ulrich C, Schmook T, Sachse M M, Sterry W, Stockfleth E. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients (Review). Dermatol Surg. 2004; 30 622-627
34 Ulrich C, Stockfleth E. UV light, azathioprine and skin cancer in organ transplant patients - do we have the answer?. Nephrol Dial Transplant. 2006; in press
35 Veness M J, Quinn D I, Ong C S. et al . Aggressive cutaneous malignancies following cardiothoracic transplantation. Cancer. 1999; 85 1758-1764
36 Vidal D, Alomar A. Efficacy of imiquimod 5 % cream for basal cell carcinoma in transplant patients. Clin Exp Dermatol. 2004; 29 237-239
37 Wang K, Zhang H, Li Y. et al . Efficacy of mycophenolate mofetil versus azathioprine after renal transplantation: a systematic review. Transplant Proc. 2004; 36 2071-2072

Professor Dr. med. Eggert Stockfleth

Klinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Berlin

Schumannstraße 20-21

10117 Berlin

Phone: 030/450518266

Fax: 030/450518966

Email: Eggert.Stockfleth@charite.de